Keyphrases
Parkinson's Disease
100%
Early Treatment
100%
Advanced Strategies
100%
Levodopa
75%
Disability
50%
Motor Symptoms
50%
Monoamine Oxidase B Inhibitors
50%
Improved Outcomes
25%
Dopamine Uptake
25%
Health Systems
25%
Imaging Studies
25%
Early Diagnosis
25%
Non-motor Symptoms
25%
Dyskinesia
25%
Rating Scales
25%
Activities of Daily Living
25%
Activities of Daily Living Scale
25%
Dopamine Agonist
25%
Treatment Delay
25%
Unified Parkinson's Disease Rating Scale (UPDRS)
25%
Motor Tests
25%
Motor Control
25%
Economic Analysis
25%
Wearing-off
25%
Treatment Other
25%
Rasagiline
25%
Non-motor
25%
Late Treatment
25%
Medicine and Dentistry
Treatment of Parkinson's Disease
100%
Levodopa
100%
Parkinson's Disease
66%
Health Care Cost
66%
Activities of Daily Living
66%
Unified Parkinson's Disease Rating Scale
66%
Amine Oxidase (Flavin Containing)
66%
Dopamine Uptake
33%
Motor Performance
33%
Early Diagnosis
33%
Dopamine Agonist
33%
Dyskinesia
33%
Rasagiline
33%
Motor Control
33%
Diagnosis of Parkinson's Disease
33%
Therapy Delay
33%
Neuroscience
Treatment of Parkinson's Disease
100%
Parkinson's Disease
100%
L-DOPA
100%
Monoamine Oxidase
66%
Monoamine Oxidase A
66%
Dopamine Uptake
33%
Dyskinesia
33%
Dopamine Agonist
33%
Motor Control
33%
Rasagiline
33%
Diagnosis of Parkinson's Disease
33%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
100%
Levodopa
60%
Amine Oxidase (Flavin Containing)
40%
Dopamine Receptor Stimulating Agent
20%
Dyskinesia
20%
Rasagiline
20%